Synapse - Works

Results (5914)

A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer

Meeting Abstract

Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
EJC Supplements (2005)

Fulltext@MSK | Save

Analysis of 1p and 19q status does not support oligodendroglial differentiation in glioneuronal tumor of adult cerebrum with neuropil-like islands (GTNI)

Meeting Abstract

Salazar, P. A.; Barbashina, V.; Ladanyi, M.; Rosenblum, M. K.
Journal of Molecular Diagnostics (2005)

Fulltext@MSK | Save

A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC

Meeting Abstract

Rizvi, N.; Pao, W.; Miller, V.; Rusch, V.; Heelan, R.; Ladanyi, M.; Ginex, P.; Tyson, L.; Zakowski, M.; Kris, M.
Lung Cancer (2005)

Fulltext@MSK | Save

Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib

Meeting Abstract

Riely, G. J.; Miller, V. A.; Pao, W.; Zakowski, M.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

EGFR mutation, immumohistochemistry (IHC) and chromogenic in situ hybridization (CISH) as predictors of sensitivity to erlotinib and gefitinib in patients (pts) with NSCLC

Meeting Abstract

Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Hussain, S.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Global gene expression profiling of epithelioid mesotheliomas and lung adenocarcinomas for the identification of new differential diagnostic markers and the development of a microarray-based prediction model

Meeting Abstract

Lopez-Rios, F.; Szoke, J.; Hussain, S.; Chuai, S.; Olshen, A. B.; Rusch, V.; Zakowski, M. F.; Gerald, W. L.; Ladanyi, M.
Modern Pathology (2005)

Fulltext@MSK | Save

Meeting Abstract

Lopez-Rios, F.; Szoke, J.; Hussain, S.; Chuai, S.; Olshen, A. B.; Rusch, V.; Zakowski, M. F.; Gerald, W. L.; Ladanyi, M.
Laboratory Investigation (2005)

Fulltext@MSK | Save

Gene expression profiling of malignant mesothelioma for prognostic prediction and identification of potential therapeutic targets and differential diagnostic markers

Meeting Abstract

Lopez-Rios, F.; Chuai, S.; Hussain, S.; Szoke, J.; Gerald, W.; Zakowski, M.; Olshen, A.; Flores, R.; Rusch, V.; Ladanyi, M.
Lung Cancer (2005)

Fulltext@MSK | Save

Clinical testing for EGFR mutations in non-small cell lung cancer: Single laboratory experience with 253 consecutive cases

Meeting Abstract

Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Pan, Q.; Ma, Y.; Miller, V. A.; Kris, M. G.; Ladanyi, M.
Journal of Molecular Diagnostics (2005)

Fulltext@MSK | Save

Global gene expression profiling of alveolar and embryonal rhabdomyosarcomas

Meeting Abstract

Lae, M.; Edgar, M.; Chuai, S.; Olshen, A. B.; Pawel, B. R.; Barr, F. G.; Ladanyi, M.
Modern Pathology (2005)

Fulltext@MSK | Save